Global Anti-inflammatory Therapeutics Market Insights and Forecast to 2031

Report ID: 1561000 | Published Date: Sep 2024 | No. of Page: 110 | Base Year: 2023 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Anti-inflammatory Biologics
        1.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
        1.2.4 Corticosteroids
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Arthritis
        1.3.3 Respiratory Diseases
        1.3.4 Dermatology
        1.3.5 Gastroenterology
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Anti-inflammatory Therapeutics Market Perspective (2017-2028)
    2.2 Anti-inflammatory Therapeutics Growth Trends by Region
        2.2.1 Anti-inflammatory Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Anti-inflammatory Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Anti-inflammatory Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Anti-inflammatory Therapeutics Market Dynamics
        2.3.1 Anti-inflammatory Therapeutics Industry Trends
        2.3.2 Anti-inflammatory Therapeutics Market Drivers
        2.3.3 Anti-inflammatory Therapeutics Market Challenges
        2.3.4 Anti-inflammatory Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Anti-inflammatory Therapeutics Players by Revenue
        3.1.1 Global Top Anti-inflammatory Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Anti-inflammatory Therapeutics Revenue
    3.4 Global Anti-inflammatory Therapeutics Market Concentration Ratio
        3.4.1 Global Anti-inflammatory Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Therapeutics Revenue in 2021
    3.5 Anti-inflammatory Therapeutics Key Players Head office and Area Served
    3.6 Key Players Anti-inflammatory Therapeutics Product Solution and Service
    3.7 Date of Enter into Anti-inflammatory Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-inflammatory Therapeutics Breakdown Data by Type
    4.1 Global Anti-inflammatory Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2023-2028)
5 Anti-inflammatory Therapeutics Breakdown Data by Application
    5.1 Global Anti-inflammatory Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Anti-inflammatory Therapeutics Market Size (2017-2028)
    6.2 North America Anti-inflammatory Therapeutics Market Size by Type
        6.2.1 North America Anti-inflammatory Therapeutics Market Size by Type (2017-2022)
        6.2.2 North America Anti-inflammatory Therapeutics Market Size by Type (2023-2028)
        6.2.3 North America Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
    6.3 North America Anti-inflammatory Therapeutics Market Size by Application
        6.3.1 North America Anti-inflammatory Therapeutics Market Size by Application (2017-2022)
        6.3.2 North America Anti-inflammatory Therapeutics Market Size by Application (2023-2028)
        6.3.3 North America Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
    6.4 North America Anti-inflammatory Therapeutics Market Size by Country
        6.4.1 North America Anti-inflammatory Therapeutics Market Size by Country (2017-2022)
        6.4.2 North America Anti-inflammatory Therapeutics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Anti-inflammatory Therapeutics Market Size (2017-2028)
    7.2 Europe Anti-inflammatory Therapeutics Market Size by Type
        7.2.1 Europe Anti-inflammatory Therapeutics Market Size by Type (2017-2022)
        7.2.2 Europe Anti-inflammatory Therapeutics Market Size by Type (2023-2028)
        7.2.3 Europe Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
    7.3 Europe Anti-inflammatory Therapeutics Market Size by Application
        7.3.1 Europe Anti-inflammatory Therapeutics Market Size by Application (2017-2022)
        7.3.2 Europe Anti-inflammatory Therapeutics Market Size by Application (2023-2028)
        7.3.3 Europe Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
    7.4 Europe Anti-inflammatory Therapeutics Market Size by Country
        7.4.1 Europe Anti-inflammatory Therapeutics Market Size by Country (2017-2022)
        7.4.2 Europe Anti-inflammatory Therapeutics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Anti-inflammatory Therapeutics Market Size (2017-2028)
    9.2 Latin America Anti-inflammatory Therapeutics Market Size by Type
        9.2.1 Latin America Anti-inflammatory Therapeutics Market Size by Type (2017-2022)
        9.2.2 Latin America Anti-inflammatory Therapeutics Market Size by Type (2023-2028)
        9.2.3 Latin America Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
    9.3 Latin America Anti-inflammatory Therapeutics Market Size by Application
        9.3.1 Latin America Anti-inflammatory Therapeutics Market Size by Application (2017-2022)
        9.3.2 Latin America Anti-inflammatory Therapeutics Market Size by Application (2023-2028)
        9.3.3 Latin America Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
    9.4 Latin America Anti-inflammatory Therapeutics Market Size by Country
        9.4.1 Latin America Anti-inflammatory Therapeutics Market Size by Country (2017-2022)
        9.4.2 Latin America Anti-inflammatory Therapeutics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 AbbVie
        11.1.1 AbbVie Company Details
        11.1.2 AbbVie Business Overview
        11.1.3 AbbVie Anti-inflammatory Therapeutics Introduction
        11.1.4 AbbVie Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
        11.1.5 AbbVie Recent Developments
    11.2 Johnson & Johnson
        11.2.1 Johnson & Johnson Company Details
        11.2.2 Johnson & Johnson Business Overview
        11.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Introduction
        11.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
        11.2.5 Johnson & Johnson Recent Developments
    11.3 Amgen Inc
        11.3.1 Amgen Inc Company Details
        11.3.2 Amgen Inc Business Overview
        11.3.3 Amgen Inc Anti-inflammatory Therapeutics Introduction
        11.3.4 Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
        11.3.5 Amgen Inc Recent Developments
    11.4 AstraZeneca PLC
        11.4.1 AstraZeneca PLC Company Details
        11.4.2 AstraZeneca PLC Business Overview
        11.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Introduction
        11.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
        11.4.5 AstraZeneca PLC Recent Developments
    11.5 Pfizer, Inc
        11.5.1 Pfizer, Inc Company Details
        11.5.2 Pfizer, Inc Business Overview
        11.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Introduction
        11.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
        11.5.5 Pfizer, Inc Recent Developments
    11.6 Novartis
        11.6.1 Novartis Company Details
        11.6.2 Novartis Business Overview
        11.6.3 Novartis Anti-inflammatory Therapeutics Introduction
        11.6.4 Novartis Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
        11.6.5 Novartis Recent Developments
    11.7 Roche
        11.7.1 Roche Company Details
        11.7.2 Roche Business Overview
        11.7.3 Roche Anti-inflammatory Therapeutics Introduction
        11.7.4 Roche Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
        11.7.5 Roche Recent Developments
    11.8 Merck
        11.8.1 Merck Company Details
        11.8.2 Merck Business Overview
        11.8.3 Merck Anti-inflammatory Therapeutics Introduction
        11.8.4 Merck Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
        11.8.5 Merck Recent Developments
    11.9 Sanofi
        11.9.1 Sanofi Company Details
        11.9.2 Sanofi Business Overview
        11.9.3 Sanofi Anti-inflammatory Therapeutics Introduction
        11.9.4 Sanofi Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
        11.9.5 Sanofi Recent Developments
    11.10 GlaxoSmithKline
        11.10.1 GlaxoSmithKline Company Details
        11.10.2 GlaxoSmithKline Business Overview
        11.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Introduction
        11.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
        11.10.5 GlaxoSmithKline Recent Developments
    11.11 Sun Pharmaceutical Industries Ltd
        11.11.1 Sun Pharmaceutical Industries Ltd Company Details
        11.11.2 Sun Pharmaceutical Industries Ltd Business Overview
        11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Introduction
        11.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
        11.11.5 Sun Pharmaceutical Industries Ltd Recent Developments
    11.12 TEVA
        11.12.1 TEVA Company Details
        11.12.2 TEVA Business Overview
        11.12.3 TEVA Anti-inflammatory Therapeutics Introduction
        11.12.4 TEVA Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
        11.12.5 TEVA Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Anti-inflammatory Biologics
    Table 3. Key Players of Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
    Table 4. Key Players of Corticosteroids
    Table 5. Key Players of Others
    Table 6. Global Anti-inflammatory Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Anti-inflammatory Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Anti-inflammatory Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Anti-inflammatory Therapeutics Market Share by Region (2017-2022)
    Table 10. Global Anti-inflammatory Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Anti-inflammatory Therapeutics Market Share by Region (2023-2028)
    Table 12. Anti-inflammatory Therapeutics Market Trends
    Table 13. Anti-inflammatory Therapeutics Market Drivers
    Table 14. Anti-inflammatory Therapeutics Market Challenges
    Table 15. Anti-inflammatory Therapeutics Market Restraints
    Table 16. Global Anti-inflammatory Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Anti-inflammatory Therapeutics Revenue Share by Players (2017-2022)
    Table 18. Global Top Anti-inflammatory Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapeutics as of 2021)
    Table 19. Ranking of Global Top Anti-inflammatory Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Anti-inflammatory Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Anti-inflammatory Therapeutics Product Solution and Service
    Table 23. Date of Enter into Anti-inflammatory Therapeutics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2017-2022)
    Table 27. Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2023-2028)
    Table 29. Global Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Anti-inflammatory Therapeutics Revenue Share by Application (2017-2022)
    Table 31. Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Anti-inflammatory Therapeutics Revenue Share by Application (2023-2028)
    Table 33. North America Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Anti-inflammatory Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Anti-inflammatory Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Anti-inflammatory Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Anti-inflammatory Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Anti-inflammatory Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Anti-inflammatory Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Anti-inflammatory Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Anti-inflammatory Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Anti-inflammatory Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Anti-inflammatory Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Anti-inflammatory Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Anti-inflammatory Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Anti-inflammatory Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Anti-inflammatory Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Anti-inflammatory Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Anti-inflammatory Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Anti-inflammatory Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Anti-inflammatory Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Anti-inflammatory Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Anti-inflammatory Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 63. AbbVie Company Details
    Table 64. AbbVie Business Overview
    Table 65. AbbVie Anti-inflammatory Therapeutics Product
    Table 66. AbbVie Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 67. AbbVie Recent Developments
    Table 68. Johnson & Johnson Company Details
    Table 69. Johnson & Johnson Business Overview
    Table 70. Johnson & Johnson Anti-inflammatory Therapeutics Product
    Table 71. Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 72. Johnson & Johnson Recent Developments
    Table 73. Amgen Inc Company Details
    Table 74. Amgen Inc Business Overview
    Table 75. Amgen Inc Anti-inflammatory Therapeutics Product
    Table 76. Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 77. Amgen Inc Recent Developments
    Table 78. AstraZeneca PLC Company Details
    Table 79. AstraZeneca PLC Business Overview
    Table 80. AstraZeneca PLC Anti-inflammatory Therapeutics Product
    Table 81. AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 82. AstraZeneca PLC Recent Developments
    Table 83. Pfizer, Inc Company Details
    Table 84. Pfizer, Inc Business Overview
    Table 85. Pfizer, Inc Anti-inflammatory Therapeutics Product
    Table 86. Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 87. Pfizer, Inc Recent Developments
    Table 88. Novartis Company Details
    Table 89. Novartis Business Overview
    Table 90. Novartis Anti-inflammatory Therapeutics Product
    Table 91. Novartis Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 92. Novartis Recent Developments
    Table 93. Roche Company Details
    Table 94. Roche Business Overview
    Table 95. Roche Anti-inflammatory Therapeutics Product
    Table 96. Roche Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 97. Roche Recent Developments
    Table 98. Merck Company Details
    Table 99. Merck Business Overview
    Table 100. Merck Anti-inflammatory Therapeutics Product
    Table 101. Merck Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 102. Merck Recent Developments
    Table 103. Sanofi Company Details
    Table 104. Sanofi Business Overview
    Table 105. Sanofi Anti-inflammatory Therapeutics Product
    Table 106. Sanofi Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 107. Sanofi Recent Developments
    Table 108. GlaxoSmithKline Company Details
    Table 109. GlaxoSmithKline Business Overview
    Table 110. GlaxoSmithKline Anti-inflammatory Therapeutics Product
    Table 111. GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 112. GlaxoSmithKline Recent Developments
    Table 113. Sun Pharmaceutical Industries Ltd Company Details
    Table 114. Sun Pharmaceutical Industries Ltd Business Overview
    Table 115. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product
    Table 116. Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 117. Sun Pharmaceutical Industries Ltd Recent Developments
    Table 118. TEVA Company Details
    Table 119. TEVA Business Overview
    Table 120. TEVA Anti-inflammatory Therapeutics Product
    Table 121. TEVA Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 122. TEVA Recent Developments
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Anti-inflammatory Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Anti-inflammatory Biologics Features
    Figure 3. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Features
    Figure 4. Corticosteroids Features
    Figure 5. Others Features
    Figure 6. Global Anti-inflammatory Therapeutics Market Share by Application: 2021 VS 2028
    Figure 7. Arthritis Case Studies
    Figure 8. Respiratory Diseases Case Studies
    Figure 9. Dermatology Case Studies
    Figure 10. Gastroenterology Case Studies
    Figure 11. Others Case Studies
    Figure 12. Anti-inflammatory Therapeutics Report Years Considered
    Figure 13. Global Anti-inflammatory Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Anti-inflammatory Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Anti-inflammatory Therapeutics Market Share by Region: 2021 VS 2028
    Figure 16. Global Anti-inflammatory Therapeutics Market Share by Players in 2021
    Figure 17. Global Top Anti-inflammatory Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapeutics as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Anti-inflammatory Therapeutics Revenue in 2021
    Figure 19. North America Anti-inflammatory Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 20. North America Anti-inflammatory Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 21. North America Anti-inflammatory Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 22. North America Anti-inflammatory Therapeutics Market Size Share by Country (2017-2028)
    Figure 23. United States Anti-inflammatory Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada Anti-inflammatory Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Anti-inflammatory Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 26. Europe Anti-inflammatory Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 27. Europe Anti-inflammatory Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 28. Europe Anti-inflammatory Therapeutics Market Size Share by Country (2017-2028)
    Figure 29. Germany Anti-inflammatory Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. France Anti-inflammatory Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. U.K. Anti-inflammatory Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Italy Anti-inflammatory Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Russia Anti-inflammatory Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Nordic Countries Anti-inflammatory Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Anti-inflammatory Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 36. Asia Pacific Anti-inflammatory Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 37. Asia Pacific Anti-inflammatory Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 38. Asia Pacific Anti-inflammatory Therapeutics Market Size Share by Region (2017-2028)
    Figure 39. China Anti-inflammatory Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Japan Anti-inflammatory Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. South Korea Anti-inflammatory Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Southeast Asia Anti-inflammatory Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. India Anti-inflammatory Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Australia Anti-inflammatory Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Latin America Anti-inflammatory Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 46. Latin America Anti-inflammatory Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 47. Latin America Anti-inflammatory Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 48. Latin America Anti-inflammatory Therapeutics Market Size Share by Country (2017-2028)
    Figure 49. Mexico Anti-inflammatory Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Brazil Anti-inflammatory Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Anti-inflammatory Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 52. Middle East and Africa Anti-inflammatory Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 53. Middle East and Africa Anti-inflammatory Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 54. Middle East and Africa Anti-inflammatory Therapeutics Market Size Share by Country (2017-2028)
    Figure 55. Turkey Anti-inflammatory Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Anti-inflammatory Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. UAE Anti-inflammatory Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. AbbVie Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 59. Johnson & Johnson Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 60. Amgen Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 61. AstraZeneca PLC Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 62. Pfizer, Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 63. Novartis Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 64. Roche Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 65. Merck Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 66. Sanofi Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 67. GlaxoSmithKline Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 68. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 69. TEVA Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA
Frequently Asked Questions
Anti-inflammatory Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Anti-inflammatory Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Anti-inflammatory Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

DC Circuit Breaker

DC Circuit Breaker market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More

Licorice Candy

Licorice Candy market is segmented by Type and by Application. Players, stakeholders, and other p ... Read More